Revolution Total Assets from 2010 to 2024

RVMDW Stock

0.36 0.04 11.18%

Revolution Medicines, Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

2.1 B

Current Value

2.2 B

Quarterly Volatility

658.8 M

Credit Downgrade

Yuan Drop

Covid

Check Revolution Medicines, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Revolution Medicines,'s main balance sheet or income statement drivers, such as Net Interest Income of 49.5 M, Interest Income of 49.9 M or Interest Expense of 287.9 K, as well as many indicators such as Price To Sales Ratio of 294, Dividend Yield of 0.0 or PTB Ratio of 1.69. Revolution financial statements analysis is a perfect complement when working with Revolution Medicines, Valuation or Volatility modules.

Check out the analysis of Revolution Medicines, Correlation against competitors.

Latest Revolution Medicines,'s Total Assets Growth Pattern

Below is the plot of the Total Assets of Revolution Medicines, Warrant over the last few years. Total assets refers to the total amount of Revolution Medicines, assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Revolution Medicines, books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Revolution Medicines,'s Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Revolution Medicines,'s overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 2.06 B

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Revolution Total Assets Regression Statistics

	Arithmetic Mean	569,940,283
	Geometric Mean	375,304,548
	Coefficient Of Variation	115.59
	Mean Deviation	466,220,282
	Median	220,529,000
	Standard Deviation	658,819,092
	Sample Variance	434042.6T
	Range	1.9B
	R-Value	0.74
	Mean Square Error	208093.9T
	R-Squared	0.55
	Significance	0
	Slope	109,729,792
	Total Sum of Squares	6076596.3T

Revolution Total Assets History

	2024	2.2 B
	2023	2.1 B
	2022	811.9 M
	2021	738 M
	2020	567.4 M

Other Fundumenentals of Revolution Medicines,

Intangibles To Total Assets

Revolution Medicines, Total Assets component correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Short Term Investments	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Intangible Assets	Current Deferred Revenue	Net Debt	Short Term Debt	Common Stock
Total Assets		1.0	-0.98	0.98	-0.98	-0.91	1.0	0.9	0.99	1.0	-0.78	1.0	-0.88	-0.97	-0.95	0.84	0.9
Total Stockholder Equity	1.0		-0.98	0.98	-0.98	-0.91	1.0	0.9	0.99	1.0	-0.77	1.0	-0.88	-0.97	-0.95	0.83	0.9
Retained Earnings	-0.98	-0.98		-0.95	0.99	0.83	-0.98	-0.93	-0.98	-0.98	0.81	-0.98	0.84	0.95	0.9	-0.91	-0.91
Accounts Payable	0.98	0.98	-0.95		-0.93	-0.94	0.97	0.84	0.95	0.98	-0.63	0.98	-0.87	-1.0	-0.99	0.75	0.9
Net Receivables	-0.98	-0.98	0.99	-0.93		0.83	-0.99	-0.92	-1.0	-0.98	0.87	-0.98	0.85	0.93	0.88	-0.89	-0.88
Good Will	-0.91	-0.91	0.83	-0.94	0.83		-0.89	-0.64	-0.86	-0.91	0.52	-0.91	0.95	0.92	0.93	-0.59	-0.71
Short Term Investments	1.0	1.0	-0.98	0.97	-0.99	-0.89		0.91	1.0	1.0	-0.81	1.0	-0.87	-0.96	-0.93	0.86	0.89
Total Liab	0.9	0.9	-0.93	0.84	-0.92	-0.64	0.91		0.91	0.9	-0.8	0.9	-0.61	-0.86	-0.82	0.9	0.95
Net Invested Capital	0.99	0.99	-0.98	0.95	-1.0	-0.86	1.0	0.91		0.99	-0.85	0.99	-0.86	-0.94	-0.9	0.87	0.88
Total Current Assets	1.0	1.0	-0.98	0.98	-0.98	-0.91	1.0	0.9	0.99		-0.76	1.0	-0.88	-0.98	-0.95	0.82	0.9
Capital Stock	-0.78	-0.77	0.81	-0.63	0.87	0.52	-0.81	-0.8	-0.85	-0.76		-0.77	0.65	0.63	0.55	-0.85	-0.63
Net Working Capital	1.0	1.0	-0.98	0.98	-0.98	-0.91	1.0	0.9	0.99	1.0	-0.77		-0.88	-0.98	-0.95	0.83	0.9
Intangible Assets	-0.88	-0.88	0.84	-0.87	0.85	0.95	-0.87	-0.61	-0.86	-0.88	0.65	-0.88		0.84	0.81	-0.68	-0.6
Current Deferred Revenue	-0.97	-0.97	0.95	-1.0	0.93	0.92	-0.96	-0.86	-0.94	-0.98	0.63	-0.98	0.84		0.99	-0.75	-0.93
Net Debt	-0.95	-0.95	0.9	-0.99	0.88	0.93	-0.93	-0.82	-0.9	-0.95	0.55	-0.95	0.81	0.99		-0.67	-0.91
Short Term Debt	0.84	0.83	-0.91	0.75	-0.89	-0.59	0.86	0.9	0.87	0.82	-0.85	0.83	-0.68	-0.75	-0.67		0.8
Common Stock	0.9	0.9	-0.91	0.9	-0.88	-0.71	0.89	0.95	0.88	0.9	-0.63	0.9	-0.6	-0.93	-0.91	0.8

Click cells to compare fundamentals

About Revolution Medicines, Financial Statements

Revolution Medicines, investors use historical fundamental indicators, such as Revolution Medicines,'s Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Revolution Medicines,. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	2.1 B	2.2 B
Intangibles To Total Assets	0.04	0.03

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Revolution Stock Analysis

When running Revolution Medicines,'s price analysis, check to measure Revolution Medicines,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines, is operating at the current time. Most of Revolution Medicines,'s value examination focuses on studying past and present price action to predict the probability of Revolution Medicines,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines,'s price. Additionally, you may evaluate how the addition of Revolution Medicines, to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC